Work productivity loss in early arthritis during the first 3 years of disease: A study from a French national multicenter cohort

Arthritis Care and Research

Volumn 66, Issue 9, 2014, Pages 1310-1318

  Dadoun, Sabrina ^a   Guillemin, Francis ^b   Lucier, Sandy ^c   Looten, Vincent ^a   Saraux, Alain ^d   Berenbaum, Francis ^e   Durand Zaleski, Isabelle ^c   Chevreul, Karine ^c   Fautrel, Bruno ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c URC ECO   (France)

^d BREST UNIVERSITY HOSPITAL   (France)

^e HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTHRITIS; ARTICLE; CONFIDENCE INTERVAL; DISABILITY; DISABILITY SEVERITY; DISEASE COURSE; EARLY ARTHRITIS; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; JOB CHARACTERISTICS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; MENTAL FUNCTION; MULTICENTER STUDY; PERMANENT DISABILITY; PHYSICAL ACTIVITY; RETIREMENT; SELF REPORT; SHORT FORM 36; UNEMPLOYMENT; WORK; WORK PRODUCTIVITY LOSS; WORKMAN COMPENSATION;

ADULT; ARTHRITIS; COHORT STUDIES; DISABLED PERSONS; EFFICIENCY; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; RETIREMENT; SICK LEAVE; WORKPLACE;

EID: 84906684885     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22298     Document Type: Article

References (52)

1. Allaire S, Wolfe F, Niu J, LaValley M, Michaud K,. Work disability and its economic effect on 55-64-year-old adults with rheumatoid arthritis. Arthritis Rheum 2005; 53: 603-8.
2. Wolfe F, Hawley DJ,. The longterm outcomes of rheumatoid arthritis. Work disability: a prospective 18 year study of 823 patients. J Rheumatol 1998; 25: 2108-17.
3. Sokka T, Kautiainen H, Mottonen T, Hannonen P,. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 1999; 26: 1681-5.
4. Woolf AD, Pfleger B,. Burden of major musculoskeletal conditions. Bull World Health Organ 2003; 81: 646-56.
5. Eklund M, Hansson L, Ahlqvist C,. The importance of work as compared to other forms of daily occupations for wellbeing and functioning among persons with long-term mental illness. Community Ment Health J 2004; 40: 465-77.
6. Hammond A,. Rehabilitation in musculoskeletal diseases. Best Pract Res Clin Rheumatol 2008; 22: 435-49.
7. Escorpizo R, Cieza A, Beaton D, Boonen A,. Content comparison of worker productivity questionnaires in arthritis and musculoskeletal conditions using the International Classification of Functioning, Disability, and Health framework. J Occup Rehabil 2009; 19: 382-97.
8. Beaton D, Bombardier C, Escorpizo R, Zhang W, Lacaille D, Boonen A, et al. Measuring worker productivity: frameworks and measures. J Rheumatol 2009; 36: 2100-9.
9. Tang K, Escorpizo R, Beaton DE, Bombardier C, Lacaille D, Zhang W, et al. Measuring the impact of arthritis on worker productivity: perspectives, methodologic issues, and contextual factors. J Rheumatol 2011; 38: 1776-90.
10. Fautrel B, Verstappen SM, Boonen A,. Economic consequences and potential benefits. Best Pract Res Clin Rheumatol 2011; 25: 607-24.
11. Allaire S, Wolfe F, Niu J, LaValley MP,. Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US. Arthritis Rheum 2008; 59: 474-80.
12. Burton W, Morrison A, Maclean R, Ruderman E,. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 2006; 56: 18-27.
13. Merkesdal S, Ruof J, Schoffski O, Bernitt K, Zeidler H, Mau W,. Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum 2001; 44: 528-34.
14. Hallert E, Husberg M, Jonsson D, Skogh T,. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project). Rheumatology (Oxford) 2004; 43: 1374-82.
15. Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Korpela M, Hakala M, et al, for the FIN-RACo Trial Group. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005; 52: 36-41.
16. Augustsson J, Neovius M, Cullinane-Carli C, Eksborg S, van Vollenhoven RF,. Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry). Ann Rheum Dis 2010; 69: 126-31.
17. Bejarano V, Quinn M, Conaghan PG, Reece R, Keenan AM, Walker D, et al, and the Yorkshire Early Arthritis Register Consortium. Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis Rheum 2008; 59: 1467-74.
18. Halpern MT, Cifaldi MA, Kvien TK,. Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group. Ann Rheum Dis 2009; 68: 930-7.
19. Olofsson T, Englund M, Saxne T, Joud A, Jacobsson LT, Geborek P, et al. Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study. Ann Rheum Dis 2010; 69: 2131-6.
20. Verstappen SM, Watson KD, Lunt M, McGrother K, Symmons DP, Hyrich KL, for the BSR Biologics Register. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 2010; 49: 1570-7.
21. Kavanaugh A, Smolen JS, Emery P, Purcaru O, Keystone E, Richard L, et al. Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis. Arthritis Rheum 2009; 61: 1592-600.
22. Anis A, Zhang W, Emery P, Sun H, Singh A, Freundlich B, et al. The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study. Rheumatology (Oxford) 2009; 48: 1283-9.
23. Neovius M, Simard JF, Klareskog L, Askling J, for the ARTIS Study Group. Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice. Ann Rheum Dis 2011; 70: 1407-14.
24. De Croon EM, Sluiter JK, Nijssen TF, Dijkmans BA, Lankhorst GJ, Frings-Dresen MH,. Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2004; 63: 1362-7.
25. Verstappen SM, Bijlsma JW, Verkleij H, Buskens E, Blaauw AA, ter Borg EJ, et al, on behalf of the Utrecht Rheumatoid Arthritis Cohort Study Group. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys [review]. Arthritis Rheum 2004; 51: 488-97.
26. Gignac MA, Sutton D, Badley EM,. Arthritis symptoms, the work environment, and the future: measuring perceived job strain among employed persons with arthritis. Arthritis Rheum 2007; 57: 738-47.
27. Lacaille D, Sheps S, Spinelli JJ, Chalmers A, Esdaile JM,. Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis. Arthritis Rheum 2004; 51: 843-52.
28. Nicassio PM, Kay MA, Custodio MK, Irwin MR, Olmstead R, Weisman MH,. An evaluation of a biopsychosocial framework for health-related quality of life and disability in rheumatoid arthritis. J Psychosom Res 2011; 71: 79-85.
29. Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daures JP, Dougados M, et al. The ESPOIR cohort: a ten-year follow-up of early arthritis in France. Methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 2007; 74: 440-5.
30. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
31. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
32. Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A,. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995; 33 Suppl: AS264-79.
33. Barber JA, Thompson SG,. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000; 19: 3219-36.
34. Kusnik-Joinville O, Lamy C, Merliere Y, Polton D,. Points de repère: déterminants de l'évolution des indemnités journalières maladie. 2006. URL: http://www.ameli.fr/fileadmin/user- upload/documents/Points-de-repere-n-5.pdf.
35. Cuerq A, Paita M, Ricordeau P,. Points de repère: les causes médicales de l'invalidité en 2006. 2008. URL: http://www.ameli.fr/ fileadmin/user-upload/documents/Points-de-repere-n-16.pdf.
36. Van Buuren S, Groothuis-Oudshoom K,. MICE: Multivariate Imputation by Chained Equations in R. J Stat Softw 2011; 45: 1-67.
37. Hallert E, Husberg M, Bernfort L,. The incidence of permanent work disability in patients with rheumatoid arthritis in Sweden 1990-2010: before and after introduction of biologic agents. Rheumatology (Oxford) 2012; 51: 338-46.
38. Neovius M, Simard JF, Askling J,. How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop? Ann Rheum Dis 2011; 70: 1010-5.
39. Bjork M, Thyberg I, Rikner K, Balogh I, Gerdle B,. Sick leave before and after diagnosis of rheumatoid arthritis: a report from the Swedish TIRA project. J Rheumatol 2009; 36: 1170-9.
40. Lenssinck ML, Burdorf A, Boonen A, Gignac MA, Hazes JM, Luime JJ,. Consequences of inflammatory arthritis for workplace productivity loss and sick leave: a systematic review. Ann Rheum Dis. 2013; 72: 493-505.
41. Puolakka K, Kautiainen H, Pekurinen M, Mottonen T, Hannonen P, Korpela M, et al. Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis 2006; 65: 899-904.
42. Kobelt G,. Thoughts on health economics in rheumatoid arthritis. Ann Rheum Dis 2007; 66 Suppl: iii35-9.
43. Franke LC, Ament AJ, van de Laar MA, Boonen A, Severens JL,. Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009; 27 Suppl: S118-23.
44. Her M, Kavanaugh A,. Critical analysis of economic tools and economic measurement applied to rheumatoid arthritis. Clin Exp Rheumatol 2012; 30 Suppl: S107-11.
45. Kobelt G, Woronoff AS, Richard B, Peeters P, Sany J,. Disease status, costs and quality of life of patients with rheumatoid arthritis in France: the ECO-PR Study. Joint Bone Spine 2008; 75: 408-15.
46. Guillemin F, Durieux S, Daures JP, Lafuma A, Saraux A, Sibilia J, et al. Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists. J Rheumatol 2004; 31: 1297-304.
47. Meenan RF, Yelin EH, Henke CJ, Curtis DL, Epstein WV,. The costs of rheumatoid arthritis: a patient-oriented study of chronic disease costs. Arthritis Rheum 1978; 21: 827-33.
48. Clarke AE, Zowall H, Levinton C, Assimakopoulos H, Sibley JT, Haga M, et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study. J Rheumatol 1997; 24: 1051-60.
49. Verstappen SM, Boonen A, Verkleij H, Bijlsma JW, Buskens E, Jacobs JW, for the Utrecht Rheumatoid Arthritis Cohort Study Group. Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity. Ann Rheum Dis 2005; 64: 1754-60.
50. Hallert E, Husberg M, Skogh T,. Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project). Rheumatology (Oxford) 2006; 45: 325-31.
51. Merkesdal S, Ruof J, Huelsemann JL, Mittendorf T, Handelmann S, Mau W, et al. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data. Arthritis Rheum 2005; 53: 234-40.
52. Zhang W, Gignac MA, Beaton D, Tang K, Anis AH, for the Canadian Arthritis Network Work Productivity Group. Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. J Rheumatol 2010; 37: 1805-14.